share_log

Ladenburg Thalmann Initiates Coverage On Peak Bio With Buy Rating, Announces Price Target of $15

Benzinga Real-time News ·  Nov 4, 2022 07:24

Ladenburg Thalmann analyst Ahu Demir initiates coverage on Peak Bio (NASDAQ:PKBO) with a Buy rating and announces Price Target of $15.

Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
    Write a comment